The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngus Energy Regulatory News (ANGS)

Share Price Information for Angus Energy (ANGS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.425
Bid: 0.40
Ask: 0.45
Change: 0.00 (0.00%)
Spread: 0.05 (12.50%)
Open: 0.425
High: 0.425
Low: 0.425
Prev. Close: 0.425
ANGS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of General Meeting

12 Oct 2023 07:00

RNS Number : 8508P
Angus Energy PLC
12 October 2023
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

12 October 2023

 

Angus Energy Plc

("Angus Energy", the "Company" or together with its subsidiaries, the "Group")

(AIM:ANGS)

 

 

Notice of General Meeting ("GM")

 

The Company announces that is has today posted a Circular to Shareholders convening a General Meeting ("GM") to be held at the offices of Fladgate LLP, 16 Great Queen Street, London WC2B 5DG on Monday 30 October 2023 at 11.00 a.m (the "Circular"). A copy of the Circular is also available from the Company's website, www.angusenergy.co.uk.

 

Extracts from the Circular are set out below including the background:

 

General Meeting

 

On 28 September 2023, the Company announced that Kemexon Ltd has agreed to convert its £3 million Junior Bridge Facility (Kemexon Facility), together with £311,378.19 of interest and £94,441.64 of fees, into equity in the Company at a price of 0.66 pence per share, which would result in the issue of 516,033,308 new Ordinary Shares in the Company (Kemexon Conversion Shares). As explained in that announcement, the Company is required to increase its Directors' authorities to enable it to issue and allot the Kemexon Conversion Shares. Application will be made to the London Stock Exchange for admission of the Kemexon Conversion Shares following the holding of the general meeting to increase the Directors' authorities, and it is expected that admission will become effective and dealings in the Kemexon Conversion Shares on AIM will commence within seven days of the holding and passing of the necessary resolutions.

In addition, the Company is required to increase its Directors' authorities to enable it to allot new Ordinary Shares in connection with the following:

1. the grant to Aleph Finance Limited of warrants to subscribe for up to 300,000,000 new Ordinary Shares (Aleph Warrant Shares) as part of the £6m Junior Bridge Facility arrangements, as announced on 21 July 2023 (Aleph Facility); and

2. in accordance with the terms of the Aleph Facility, the allotment of shares in connection with any future agreement between the Company and Aleph regarding the repayment of the Aleph Facility in equity on maturity in lieu of cash, in either case up to a maximum of 1,500,000,000 new Ordinary Shares (Aleph Facility Shares).

 

In respect of point 2 above, it is a requirement of the Aleph Facility that the Company seek Shareholder approval for the necessary authority to issue such number of Ordinary Shares to be issued regarding mutual agreement to repay the Aleph Facility and therefore whilst the Company does not currently expect these Ordinary Shares to be issued given the ongoing discussions to complete a global refinance of this and other Company indebtedness, it is complying with these requirements now in putting such resolutions to Shareholders. 

Accordingly, the Company is now convening a general meeting (GM) to table the necessary shareholder resolutions to enable the Directors to allot new Ordinary Shares in accordance with the above, being:

1. resolutions to authorise the issue of new Ordinary Shares comprising the Kemexon Conversion Shares, the Aleph Warrant Shares and the Aleph Facility Shares, and to disapply statutory pre-emption rights in respect of such allotments; and

 

2. to authorise the Directors to allot further Ordinary Shares and to disapply statutory pre-emption rights in respect of allotment up to a certain amount. This will give the Directors flexibility to allot further Ordinary Shares in the future should they consider it to be in the best interests of the Company to do so.

 

END

 

For further information on the Company, please visit www.angusenergy.co.uk or contact:

Enquiries:

 

Angus Energy Plc www.angusenergy.co.uk

 

Richard Herbert Tel: +44 (0) 208 899 6380

Beaumont Cornish Limited (Nomad) www.beaumontcornish.com

 

James Biddle / Roland Cornish Tel: +44 (0) 207 628 3396

WH Ireland Limited (Broker)

 

Katy Mitchell / Harry Ansell Tel: +44 (0) 207 220 1666

Flagstaff PR/IR angus@flagstaffcomms.com

 

Tim Thompson / Fergus Mellon Tel: +44 (0) 207 129 1474

 

Aleph Commodities info@alephcommodities.com

 

Disclaimers - this Announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "forecasts", "plans", "prepares", "anticipates", "projects", "expects", "intends", "may", "will", "seeks", "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this Announcement and include statements regarding the Company's and the Directors' intentions, beliefs or current expectations concerning, amongst other things, the Company's prospects, growth and strategy. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance. The Company's actual performance, achievements and financial condition may differ materially from those expressed or implied by the forward-looking statements in this Announcement. In addition, even if the Company's results of operations, performance, achievements and financial condition are consistent with the forward-looking statements in this Announcement, those results or developments may not be indicative of results or developments in subsequent periods. Any forward-looking statements that the Company makes in this Announcement speak only as of the date of such statement and (other than in accordance with their legal or regulatory obligations) neither the Company, nor the Bookrunner nor Beaumont Cornish nor any of their respective associates, directors, officers or advisers shall be obliged to update such statements. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed as such, and should only be viewed as historical data.

Beaumont Cornish Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as nominated adviser to the Company in relation to the matters referred herein. Beaumont Cornish Limited is acting exclusively for the Company and for no one else in relation to the matters described in this announcement and is not advising any other person and accordingly will not be responsible to anyone other than the Company for providing the protections afforded to clients of Beaumont Cornish Limited, or for providing advice in relation to the contents of this announcement or any matter referred to in it.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGFFWFUFEDSEFS
Date   Source Headline
24th Jun 20197:00 amRNSHalf-year Report
19th Jun 201910:01 amRNSAcquisition of Interest in Saltfleetby Gas Field
3rd Jun 20192:05 pmRNSSecond Price Monitoring Extn
3rd Jun 20192:00 pmRNSPrice Monitoring Extension
3rd Jun 20197:00 amRNSBrockham Operations Update
29th May 20197:00 amRNSResults of Open Offer
10th May 20199:30 amRNSBrockham Operations Update
10th May 20197:00 amRNSOpen Offer Circular published
3rd May 20197:00 amRNSBrockham Operations Update
30th Apr 20199:26 amRNSResult of Placing
30th Apr 20197:00 amRNSProposed Placing and Open Offer
25th Apr 20196:30 pmRNSBrockham Operations Update
18th Apr 20197:00 amRNSCompletion of Acquisition of Lidsey interest
10th Apr 201910:00 amRNSOperations Update: Brockham
5th Apr 20194:45 pmRNSOperations Update: Brockham
3rd Apr 20197:00 amRNSOperations Update & Schedule of Works at Brockham
2nd Apr 20194:49 pmRNSTotal Voting Rights
29th Mar 201911:53 amRNSResult of AGM
21st Mar 201912:00 pmRNSOperations Update: Rig Contract for Brockham
18th Mar 20194:41 pmRNSSecond Price Monitoring Extn
18th Mar 20194:36 pmRNSPrice Monitoring Extension
14th Mar 20197:00 amRNSSPA signed regarding additional interest in Lidsey
14th Mar 20197:00 amRNSUpdate on PEDL 143 (Holmwood)
7th Mar 20197:00 amRNSNotice of AGM
6th Mar 20193:15 pmRNSBoard Changes
6th Mar 20197:00 amRNSAnnual Financial Report
26th Feb 20194:45 pmRNSOperations and Lidsey Field Interest Update
19th Feb 201910:27 amRNSVariation to Planning Consent at Lidsey
15th Feb 20197:00 amRNSEquity Placing
14th Feb 20197:00 amRNSUpdate to Financing Arrangement
8th Feb 20195:27 pmRNSBalcombe Update and Holdings in Company
8th Feb 20194:41 pmRNSSecond Price Monitoring Extn
8th Feb 20194:35 pmRNSPrice Monitoring Extension
4th Feb 20197:00 amRNSBrockham Well Test Update
29th Jan 20194:40 pmRNSSecond Price Monitoring Extn
29th Jan 20194:35 pmRNSPrice Monitoring Extension
29th Jan 20197:00 amRNSRetraction of Requisition of GM & Board Changes
10th Jan 20194:41 pmRNSSecond Price Monitoring Extn
10th Jan 20194:35 pmRNSPrice Monitoring Extension
10th Jan 20192:06 pmRNSSecond Price Monitoring Extn
10th Jan 20192:00 pmRNSPrice Monitoring Extension
10th Jan 201911:05 amRNSSecond Price Monitoring Extn
10th Jan 201911:00 amRNSPrice Monitoring Extension
10th Jan 20197:00 amRNSOperations update, Financing, GM requisition
19th Dec 20187:00 amRNSOperations update
21st Nov 201812:19 pmRNSReplacement: Result of General Meeting
21st Nov 201811:57 amRNSResult of General Meeting
5th Nov 20189:05 amRNSSecond Price Monitoring Extn
5th Nov 20189:00 amRNSPrice Monitoring Extension
5th Nov 20187:00 amRNSProposed placing to raise £2.0 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.